By Raj Grover
Canada has a chance to become Europe's top medical cannabis partner as demand surges in foreign markets, particularly in Germany.
Prime Minister has set a goal to double Canada's non-U.S. exports within the next decade, generating an estimated $300 billion in additional trade.
The medical cannabis industry is well-positioned to contribute to this goal, combining global demand with proven domestic expertise and strong regulatory credibility.
Canada must focus on sectors that combine global demand with proven domestic expertise and strong regulatory credibility.
Author's summary: Canada can become Europe's top medical cannabis partner.